TWST

Twist Bioscience Corporation is a leading synthetic biology company that leverages a proprietary silicon-based manufacturing platform to produce high-quality synthetic DNA at scale. Founded in 2013, the company has revolutionized the field by enabling the rapid, high-throughput synthesis of oligonucleotides, which are essential building blocks for diverse applications in medicine, agriculture, and industrial chemicals. Their technology platform supports a wide range of products, including synthetic genes, tools for next-generation sequencing, and antibody libraries for drug discovery. By providing researchers with custom DNA sequences, Twist facilitates advancements in genomics, diagnostics, and therapeutics development. The company’s innovative approach to miniaturization allows for greater efficiency and lower costs in biological research, positioning it as a foundational infrastructure provider for the expanding biotechnology sector. Through these advancements, Twist Bioscience plays a critical role in accelerating the pace of modern scientific breakthroughs and personalized medicine.